These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 10965310

  • 1. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates.
    Foitzik T, Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ.
    Surgery; 2000 Sep; 128(3):399-407. PubMed ID: 10965310
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist.
    Foitzik T, Eibl G, Buhr HJ.
    J Gastrointest Surg; 2000 Sep; 4(3):240-6; discussion 247. PubMed ID: 10769086
    [Abstract] [Full Text] [Related]

  • 4. [Endothelin receptor block in acute pancreatitis--improvement of microcirculation and decrease of capillary permeability also distant from the pancreas].
    Foitzik T, Hotz HG, Eibl G, Faulhaber J, Kirchengast M, Buhr HJ.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Sep; 115(Suppl I):427-9. PubMed ID: 14518290
    [Abstract] [Full Text] [Related]

  • 5. Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis.
    Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ.
    Ann Surg; 1998 Nov; 228(5):670-5. PubMed ID: 9833805
    [Abstract] [Full Text] [Related]

  • 6. Endothelin A but not endothelin B receptor blockade reduces capillary permeability in severe experimental pancreatitis.
    Eibl G, Forgacs B, Hotz HG, Buhr HJ, Foitzik T.
    Pancreas; 2002 Aug; 25(2):e15-20. PubMed ID: 12142750
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block?
    Eibl G, Buhr HJ, Foitzik T.
    Intensive Care Med; 2002 Feb; 28(2):139-46. PubMed ID: 11907656
    [Abstract] [Full Text] [Related]

  • 10. Endothelin mediates local and systemic disease sequelae in severe experimental pancreatitis.
    Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ.
    Pancreas; 2001 Apr; 22(3):248-54. PubMed ID: 11291925
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats.
    Kruschewski M, Anderson T, Loddenkemper C, Buhr HJ.
    Dig Dis Sci; 2006 Aug; 51(8):1461-70. PubMed ID: 16868834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis.
    Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ, Foitzik T.
    Gut; 2000 Mar; 46(3):390-4. PubMed ID: 10673302
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.